​

Sotera Health (SHC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SHC Stock Forecast

Sotera Health (SHC) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $18.50, with a high of $20.00 and a low of $17.00. This represents a 9.47% increase from the last price of $16.90.

$11 $12 $13 $14 $15 $16 $17 $18 $19 $20 High: $20 Avg: $18.5 Low: $17 Last Closed Price: $16.9

SHC Stock Rating

Sotera Health stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (83.33%), 2 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 2 10 0 Strong Sell Sell Hold Buy Strong Buy

SHC Price Target Upside V Benchmarks

TypeNameUpside
StockSotera Health9.47%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks6.89%

Price Target Trends

1M3M12M
# Anlaysts-34
Avg Price Target-$18.67$18.25
Last Closing Price$16.90$16.90$16.90
Upside/Downside-10.47%7.99%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25143--8
Nov, 25133--7
Oct, 25133--7
Sep, 25133--7
Aug, 25133--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2025Piper Sandler$17.00$16.155.26%0.59%
Nov 05, 2025Barclays$20.00$16.4321.73%18.34%
Oct 02, 2025Barclays$19.00$16.1917.36%12.43%
May 05, 2025Matthew SykesGoldman Sachs$17.00$12.9231.58%0.59%
Dec 05, 2024David WindleyJefferies$15.00$12.9815.56%-11.24%
Nov 06, 2024David WindleyJefferies$18.00$15.2717.88%6.51%
Aug 06, 2024Luke SergottBarclays$17.00$14.2219.55%0.59%
Jun 06, 2024David WindleyJefferies$14.50$11.9821.04%-14.20%
May 21, 2024Jason BednarPiper Sandler$13.00$10.9119.16%-23.08%
May 03, 2024Sean DodgeRBC Capital$17.00$10.9155.82%0.59%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 05, 2025Piper SandlerNeutralNeutralhold
Nov 05, 2025BarclaysOverweightOverweighthold
Oct 07, 2025CitigroupNeutralNeutralhold
Oct 02, 2025BarclaysOverweightOverweighthold
Aug 08, 2025BarclaysOverweightOverweighthold
May 05, 2025Goldman SachsNeutralBuyupgrade
Dec 05, 2024JefferiesBuyBuyhold
Nov 05, 2024CitigroupBuyBuyhold
Aug 06, 2024BarclaysOverweightOverweighthold
Aug 05, 2024KeyBancSector WeightSector Weighthold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-0.13$0.41$-0.83$0.18$0.16---
Avg Forecast$0.38$0.87$0.93$0.81$0.69$0.79$0.90$0.98
High Forecast$0.38$0.88$0.95$0.82$0.71$0.81$0.99$1.00
Low Forecast$0.37$0.87$0.92$0.80$0.68$0.77$0.80$0.96
Surprise %-134.21%-52.87%-189.25%-77.78%-76.81%---

Revenue Forecast

$800M $900M $1B $1B $1B $1B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$818.16M$931.48M$1.00B$1.05B$1.10B---
Avg Forecast$815.86M$926.73M$1.00B$1.04B$1.10B$1.16B$1.23B$1.28B
High Forecast$820.05M$931.49M$1.01B$1.05B$1.12B$1.18B$1.23B$1.30B
Low Forecast$810.23M$920.33M$990.36M$1.03B$1.09B$1.15B$1.23B$1.26B
Surprise %0.28%0.51%0.28%0.78%-0.04%---

Net Income Forecast

$-250M $-140M $-30M $80M $190M $300M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-37.49M$116.88M$-233.57M$51.38M$44.40M---
Avg Forecast$107.08M$247.68M$264.38M$229.79M$196.70M$223.01M$254.09M$277.71M
High Forecast$107.79M$249.34M$267.98M$232.59M$199.87M$228.72M$280.56M$282.55M
Low Forecast$106.12M$245.46M$260.79M$226.99M$193.53M$217.29M$227.63M$272.87M
Surprise %-135.01%-52.81%-188.34%-77.64%-77.43%---

SHC Forecast FAQ

Is Sotera Health stock a buy?

Sotera Health stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Sotera Health is a favorable investment for most analysts.

What is Sotera Health's price target?

Sotera Health's price target, set by 12 Wall Street analysts, averages $18.5 over the next 12 months. The price target range spans from $17 at the low end to $20 at the high end, suggesting a potential 9.47% change from the previous closing price of $16.9.

How does Sotera Health stock forecast compare to its benchmarks?

Sotera Health's stock forecast shows a 9.47% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (6.89%).

What is the breakdown of analyst ratings for Sotera Health over the past three months?

  • December 2025: 12.50% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 14.29% Strong Buy, 42.86% Buy, 42.86% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 14.29% Strong Buy, 42.86% Buy, 42.86% Hold, 0% Sell, 0% Strong Sell.

What is Sotera Health’s EPS forecast?

Sotera Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.79, marking a 393.75% increase from the reported $0.16 in 2024. Estimates for the following years are $0.9 in 2026, and $0.98 in 2027.

What is Sotera Health’s revenue forecast?

Sotera Health's average annual revenue forecast for its fiscal year ending in December 2025 is $1.16B, reflecting a 5.26% increase from the reported $1.1B in 2024. The forecast for 2026 is $1.23B, and $1.28B for 2027.

What is Sotera Health’s net income forecast?

Sotera Health's net income forecast for the fiscal year ending in December 2025 stands at $223.01M, representing an 402.29% increase from the reported $44.4M in 2024. Projections indicate $254.09M in 2026, and $277.71M in 2027.